Status:
TERMINATED
Wound Protector Dual-ring Alexis® in Pancreaticoduodenectomy
Lead Sponsor:
Azienda Ospedaliera Universitaria Integrata Verona
Conditions:
Surgical Site Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Surgical site infection (SSI) is a leading cause of preventable morbidity and mortality in North America and worldwide. This condition has consistently been reported to account for up to 25% of all he...
Detailed Description
Surgical site infection (SSI) is a leading cause of preventable morbidity and mortality in North America and worldwide. This condition has consistently been reported to account for up to 25% of all he...
Eligibility Criteria
Inclusion
- Scheduled for elective PD
- Age ≥ 18 years
- Ability of the subject to understand character and individual consequences of the clinical trial
- Written informed consent
Exclusion
- Under 18 years of age
- Unable to sign informed consent
Key Trial Info
Start Date :
September 7 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 9 2019
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT03820648
Start Date
September 7 2017
End Date
December 9 2019
Last Update
January 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOUI Verona
Verona, Italy, 37124